Putnam Investments’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-16,239
Closed -$527K 1285
2021
Q4
$527K Buy
+16,239
New +$527K ﹤0.01% 980